CHRONIC HEART FAILURE AND DIABETES MELLITUS TYPE 2:  QUALITY OF LIFE AND POSSIBILITY OF ITS CORRECTION

dc.contributor.author	Pavlyukovich, N.
dc.contributor.author	Pavlyukovich, O.
dc.contributor.author	Buriak, O.G.
dc.contributor.author	Chympoy, C.
dc.date.accessioned	2017-02-20T10:47:40Z
dc.date.available	2017-02-20T10:47:40Z
dc.date.issued	2016
dc.identifier.other	УДК 616.12-008.46:616.379-008.64]-07-0361-085.225.2
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/12115
dc.description.abstract	Chronic heart failure of ischemic origin complicated by concomitant diabetes mellitus type 2 is characterized by significant decreasing of the quality of life in general, and of physical and psychological welfare, self-service and independence of action, same as personal implementation particularly. Inclusion of telmisartan to the scheme of complex treatment of the patients with chronic heart failure and diabetes mellitus type 2 results in the improvement of the patients’ quality of life as well as its main components	ru_RU
dc.language.iso	en	ru_RU
dc.publisher	“THE UNITY OF SCIENCE” April, 2016	ru_RU
dc.subject	chronic heart failure	ru_RU
dc.subject	diabetes mellitus type 2	ru_RU
dc.subject	quality of life	ru_RU
dc.subject	telmisartan	ru_RU
dc.title	CHRONIC HEART FAILURE AND DIABETES MELLITUS TYPE 2: QUALITY OF LIFE AND POSSIBILITY OF ITS CORRECTION	ru_RU
dc.type	Article	ru_RU